These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Biology of anti-angiogenic therapy-induced thrombotic microangiopathy.
    Author: Eremina V, Quaggin SE.
    Journal: Semin Nephrol; 2010 Nov; 30(6):582-90. PubMed ID: 21146123.
    Abstract:
    Anti-vascular endothelial growth factor (VEGF) agents are an important component in the treatment of many solid tumors. As the indications for these targeted therapies grow, the expected number of patients to receive these drugs will increase exponentially. Despite the great promise, serious toxicities may arise. Here, we discuss the incidence, pathogenesis, and management of proteinuria and renal insufficiency associated with this class of drugs.
    [Abstract] [Full Text] [Related] [New Search]